LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma

The authors have withdrawn their manuscript owing to massive revision and data validation. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

• Publication year

  2023

• Venue

  bioRxiv

• Publication date

  2023-04-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2139/ssrn.4387831PMID 37131765PMCID 10153221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.

  2023cited by this paper
• Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.

  2022cited by this paper
• Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors

  2022cited by this paper
• Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes

  2022cited by this paper
• Methyl-CpG binding protein 2 (MeCP2) as a potential diagnostic and prognostic marker facilitates glioma progression through activation of the Wnt/β-Catenin pathway.

  2022cited by this paper
• scSorter: assigning cells to known cell types according to marker genes

  2021cited by this paper
• Gene biomarker prediction in glioma by integrating scRNA-seq data and gene regulatory network

  2021cited by this paper
• Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data

  2021cited by this paper
• Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states

  2021cited by this paper
• Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples

  2020cited by this paper
• IDH1-R132H Suppresses Glioblastoma Malignancy through FAT1-ROS-HIF-1α Signaling

  2020cited by this paper
• Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth

  2020cited by this paper
• Gene Biomarker Prediction in Glioma by Integrating scRNA-seq Data and the Gene Regulatory Network

  2020cited by this paper
• Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches

  2020cited by this paper
• Surveying Brain Tumor Heterogeneity by Single-Cell RNA Sequencing of Multi-sector Biopsies

  2020cited by this paper
• Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.

  2020cited by this paper
• Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies

  2020cited by this paper
• BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma

  2019cited by this paper
• An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

  2019cited by this paper
• Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.

  2019cited by this paper
• Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment

  2019cited by this paper
• Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF‐β1/Smad signaling pathway

  2019cited by this paper
• A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.

  2019cited by this paper
• Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas

  2019cited by this paper
• STEM-26. ALTERED LIPID METABOLISM MARKS GLIOBLASTOMA STEM AND NON-STEM CELLS IN SEPARATE TUMOR NICHES

  2019cited by this paper
• Aconitase 2 inhibits the proliferation of MCF-7 cells promoting mitochondrial oxidative metabolism and ROS/FoxO1-mediated autophagic response

  2019cited by this paper
• Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

  2019cited by this paper
• Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma

  2018cited by this paper
• Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities

  2018cited by this paper
• Single-Cell RNAseq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma

  2017cited by this paper
• Up‐regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine‐resistant pancreatic cancer cells

  2017cited by this paper
• The Two Faces of Reactive Oxygen Species in Cancer.

  2017cited by this paper
• IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway

  2017cited by this paper
• Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Mitochondrial Lon is over-expressed in high-grade gliomas, and mediates hypoxic adaptation: potential role of Lon as a therapeutic target in glioma

  2016cited by this paper
• Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.

  2016cited by this paper
• A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.

  2016cited by this paper
• Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse.

  2016cited by this paper
• R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.

  2016cited by this paper
• Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi

  2016cited by this paper
• Isolation and culture of primary glioblastoma cells from human tumor specimens.

  2015cited by this paper
• Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo

  2015cited by this paper
• Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.

  2015cited by this paper
• Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.

  2014cited by this paper
• ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity.

  2014cited by this paper
• Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species

  2013cited by this paper
• Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas.

  2013cited by this paper
• Mitochondrial DNA Instability in Cells Lacking Aconitase Correlates with Iron Citrate Toxicity

  2013cited by this paper
• CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

  2013cited by this paper
• p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells

  2012cited by this paper
• Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.

  2012cited by this paper
• IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma

  2012cited by this paper
• Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells

  2012cited by this paper
• Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma

  2011cited by this paper
• Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

  2011cited by this paper
• R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma

  2011cited by this paper
• Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma

  2010cited by this paper
• The prognostic IDH1R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma

  2010cited by this paper
• HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress.

  2009cited by this paper
• Escape from flatland: increasing saturation as an approach to improving clinical success.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Diagnosis and treatment of high-grade astrocytoma.

  2007cited by this paper
• A population‐based description of glioblastoma multiforme in Los Angeles County, 1974–1999

  2005cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo.

  2004cited by this paper
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Modulation of the Chymotrypsin-Like Activity of the 20S Proteasome by Intracellular Redox Status: Effects of Glutathione Peroxidase-1 Overexpression and Antioxidant Drugs

  2003cited by this paper
• The proteasome: structure, function, and role in the cell.

  2003cited by this paper
• Reactive oxygen species in oncogenic transformation.

  2003cited by this paper
• Quiescent hypervascularity mediated by gain of HIF-1 alpha function.

  2002cited by this paper
• Quiescent Hypervascularity Mediated by Gain of HIF-1α Function

  2002cited by this paper
• Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.

  2000cited by this paper
• EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with temozolomide-based radiochemotherapy versus temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma.

  year unknowncited by this paper

• Modulation of Lonp1 Activity by Small Compounds

  2025cites this paper
• Acetylation of mtHSP70 at Lys595/653 affecting its interaction between GrpEL1 regulates glioblastoma progression via UPRmt.

  2024cites this paper